TABLE 4.
Current immunosuppression maintenance regimens
Type of immunomodulation | Subjects# |
Low-dose corticosteroids | 9 (75%) |
Mycophenolate mofetil | 5 (42%) |
Hydroxychloroquine | 4 (33%) |
Azathioprine | 3 (25%) |
Rituximab | 2 (16%) |
Etanercept | 2 (16%) |
Methotrexate | 2 (16%) |
IVIG | 2 (16%) |
Combination therapies | |
One agents | 4 (33%) |
Two agents | 3 (25%) |
More than two agents | 5 (42%) |
IVIG: intravenous immunoglobulin. #: N=12.